Age-related changes to the cell’s transcriptional machinery blunt overall gene expression, skewing cells toward shorter genes and elevating stress-response programs, according to a new study from Northwestern Medicine published in the Proceedings of the National Academy of Sciences.
What researchers did and found
Scientists led by Ali Shilatifard used a multimodal sequencing approach on tissue from young (11 weeks) and old (72 weeks) mice — examining liver, kidney and brain — and cross-checked those signals against publicly available human total RNA-seq datasets. Short-read RNA sequencing showed a drop in overall transcriptional activity and fewer transcription events in aged tissues, despite no detectable change in RNA polymerase II elongation speed.
Transcript-level analyses revealed a consistent shift: aging tissues preferentially express short genes, with a concurrent upregulation of short stress-response genes and a downregulation of long neurodevelopmental genes in the aging mouse brain. Those same patterns were also observed in human samples, strengthening the relevance to human aging.
"Characterizing the impacts of aging on this transcriptional machinery... may reveal new targets for the development of anti-aging therapies," said Ali Shilatifard, senior author of the study.
Mechanism: polymerase interactions and splicing defects
The team looked beyond expression counts to molecular interactions and RNA isoforms. They report reduced association between RNA polymerase II and the Mediator complex in chromatin from aged liver and brain tissue — a link that may impair the communication between DNA-bound regulators and the core transcription engine.
Using long-read sequencing, researchers observed more aberrant splice isoforms in aged mouse brains, notably an increase in mono-exonic transcripts and events of intron retention. Those splicing irregularities help explain why long genes—which require more complex processing—appear especially vulnerable in aging.
Why this matters
- Precision of gene output: Reductions in transcription and altered polymerase–Mediator interactions could underlie functional decline in aging tissues, particularly the brain.
- Long neuronal genes at risk: Neurodevelopmental and neuronal maintenance genes tend to be long; their selective loss could tie directly to age-associated cognitive and neuronal changes.
- Therapeutic targets: Restoring polymerase–Mediator coupling or correcting splicing fidelity are plausible intervention points the study highlights.
| Specimen | Age points | Main transcriptional change |
|---|---|---|
| Mouse brain | 11 weeks vs 72 weeks | Downregulation of long neurodevelopmental genes; more aberrant splice isoforms |
| Mouse liver, kidney | 11 weeks vs 72 weeks | Reduced transcription activity; decreased RNA Pol II–Mediator interactions |
| Human tissues | young vs aged (public datasets) | Similar shift favoring short genes and stress-response upregulation |
The study ties three related phenomena — reduced transcriptional frequency, weakened polymerase–Mediator coupling, and increased splicing errors — into a coherent picture of how aging may reshape the transcriptome. That coherence, and the replication in human datasets, raise the findings above an isolated mouse observation and into a map of actionable biology.
For researchers and companies pursuing anti‑aging approaches, the data suggest concrete molecular processes to probe: can interventions preserve polymerase–Mediator interactions, enhance splicing fidelity for long genes, or otherwise rebalance the transcriptome? The study does not test therapies, but it narrows where those therapies might act.
As age-related disorders continue to burden health systems, understanding the mechanics of transcriptional decline gives scientists clearer biochemical targets. The path from those molecular targets to safe, effective therapies is long, but these results add a critical piece to the puzzle of cellular aging.
